14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Alloxan Diabetes in 2 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fu, M | 1 |
Yu, J | 1 |
Chen, Z | 1 |
Tang, Y | 1 |
Dong, R | 1 |
Yang, Y | 1 |
Luo, J | 1 |
Hu, S | 1 |
Tu, L | 1 |
Xu, X | 1 |
Alaeddine, LM | 1 |
Harb, F | 1 |
Hamza, M | 1 |
Dia, B | 1 |
Mogharbil, N | 1 |
Azar, NS | 1 |
Noureldein, MH | 1 |
El Khoury, M | 1 |
Sabra, R | 1 |
Eid, AA | 1 |
2 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Alloxan Diabetes
Article | Year |
---|---|
Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-κB-mediated transcription of SGLT2 in renal tubular epithelial cells.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cell Line; Diabetes Mellitus, Experimental; Epithelial Cells; | 2021 |
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme Sy | 2021 |